Department of Pediatrics Archives
Fellowships reflect Michal’s deep commitment to children
Dec. 7, 2017—Mary Michal, MD,’60, may have entered Vanderbilt University School of Medicine by mistake, but she’s remained devoted to its mission by design.
Trevathan named director for the Vanderbilt Institute for Global Health
Nov. 20, 2017—Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018.
Boosting sarcoma cell death
Oct. 4, 2017—A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.
Delirium, benzos and the pediatric ICU
Oct. 2, 2017—With other risk factors held equal, children who received a benzodiazepine sedative drug were nearly three times more likely to experience delirium – confused thought – the following day.
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.
Address highlights Pediatrics’ people, progress, growth
Sep. 7, 2017—Steven Webber, MBChB, MRCP, delivered the annual State of the Department of Pediatrics address on Tuesday, with growth and quality improvement serving as recurring themes along with a focus on the department’s four mission areas — discovery, clinical care, education and advocacy, service and community partnerships.
Doris Duke Foundation lauds Van Driest’s research
Jul. 27, 2017—Sara Van Driest, M.D., Ph.D., who is developing methods for precision dosing of pediatric medications at Vanderbilt University Medical Center (VUMC), has received a 2017 Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
Bile acids, microbiota and colon cancer
Jul. 5, 2017—Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis.
Team investigates antiviral that inhibits SARS, MERS
Jun. 29, 2017—A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.
Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children
Jun. 22, 2017—In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.
Patrick honored for neonatal abstinence syndrome research
Jun. 15, 2017—Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero.
New screening model quickly spots acute kidney injury
Jun. 8, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have developed a screening tool intended to more quickly identify patients with acute kidney injury (AKI).
